TNF Adalimumab Biosimilar anti-Human, Unconjugated, Clone: Adalimumab.rMAb (also known as Adalimumab Biosimilar.rMAb), BD Phrmingen™
Manufacturer: BD Biosciences
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | BDB569601-Each-of-1 | In Stock | ₹ 48,638.50 |
BDB569601 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 48,638.50
GST (18%): ₹ 8,754.93
Total Price: ₹ 57,393.43
Antigen
TNF Adalimumab Biosimilar
Classification
Monoclonal
Concentration
1.0 mg/mL
Formulation
No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2 μm sterile filtered. Endotoxin level is ≤0.01 EU/μg (≤0.001 ng/μg) of protein as determined by the LAL assay.
Immunogen
Human TNF
Quantity
0.5 mg
Primary or Secondary
Primary
Target Species
Human
Form
Liquid
Applications
ELISA, Neutralization
Clone
Adalimumab.rMAb (also known as Adalimumab Biosimilar.rMAb)
Conjugate
Unconjugated
Gene Alias
TNF; TNF-a; TNF-alpha; TNFA; TNFSF2
Purification Method
Affinity Chromatography
Regulatory Status
RUO
Gene ID (Entrez)
7124
Content And Storage
Store undiluted at 4°C. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
Isotype
IgG1 κ
Related Products
Description
- TNF Adalimumab Biosimilar Monoclonal antibody specifically detects TNF Adalimumab Biosimilar in Human samples
- It is validated for ELISA|Neutralization